tiprankstipranks
Trending News
More News >
OncoTherapy Science, Inc. (DE:30O)
:30O
Germany Market

OncoTherapy Science (30O) Cash flow

Compare
0 Followers

OncoTherapy Science Cash Flow

DE:30O's free cash flow for Q3 2024 was ¥0.00. For the 2024 fiscal year, DE:30O's free cash flow was decreased by ¥415.32M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Mar 25Mar 24Mar 23Mar 22Mar 21
Operating Cash Flow
¥ -815.02M¥ -1.23B¥ -794.90M¥ -2.07B¥ -1.76B
Investing Cash Flow
¥ -279.00K¥ -33.35M¥ -20.32M¥ -467.93M¥ -52.23M
Financing Cash Flow
¥ 1.12B¥ 671.37M¥ 95.95M¥ 1.48B¥ 0.00
End Cash Position
¥ 833.88M¥ 527.66M¥ 1.12B¥ 1.84B¥ 2.90B
Free Cash Flow
¥ -815.30M¥ -1.23B¥ -800.29M¥ -2.53B¥ -1.81B
Currency in JPY

OncoTherapy Science Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis